Francesca Dickins | Advisor, Medicines Quality Organization
Eli Lilly

Francesca joined Lilly in 2001 and is currently an Advisor (Regulatory), MQO International. With over 20 years of experience in regulatory and quality roles within the pharmaceutical industry, Francesca has deep expertise in product licensing, labelling development, inspection, audit, deviation and change control management and regulatory aspects of clinical trials. In 2012, Francesca was seconded to the ABPI to support the Head of Regulatory Affairs and Drug Safety during a challenging period of UK regulation change. Since 2020, Francesca has played a pivotal role as a Quality Lead in process design and improvement initiatives. Francesca has been instrumental in developing robust Clinical Trials Reference Safety Information (RSI) processes and establishing the RSI Centre of Excellence (CoE). Francesca has been involved with several professional societies and committees, contributing to the field of regulatory affairs. These include The Organisation for Professionals In Regulatory Affairs (TOPRA), Regulatory Affairs Professionals Society (RAPS), Drug Information Association (DIA), Association of the British Pharmaceutical Industry (ABPI), and Labelnet.